Share chart Leap Therapeutics, Inc.
Extended chart
Simple chart
About Leap Therapeutics, Inc.
Leap Therapeutics, Inc., биофармацевтическая компания, приобретает и разрабатывает методы лечения рака. Его ведущие программы клинической стадии включают DKN-01, моноклональное антитело, которое ингибирует родственный Dickkopf белок 1, который проходит многочисленные клинические испытания для лечения рака пищевода, желудка, гепатобилиарной системы, гинекологического рака и рака простаты. Компания ранее называлась HealthCare Pharmaceuticals, Inc. и сменила название на Leap Therapeutics, Inc. в ноябре 2015 года. Leap Therapeutics, Inc. more details| IPO date | 2017-01-25 |
|---|---|
| ISIN | US52187K1016 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.leaptx.com |
| Цена ао | 0.388 |
| Change price per day: | +1.73% (0.3931) |
|---|---|
| Change price per week: | +10.04% (0.3634) |
| Change price per month: | -11.82% (0.4535) |
| Change price per 3 month: | -81.4% (2.15) |
| Change price per half year: | -90.36% (4.15) |
| Change price per year: | -87.7% (3.25) |
| Change price per 3 year: | -70.6% (1.36) |
| Change price per 5 year: | -77.53% (1.78) |
| Change price per year to date: | -85.62% (2.78) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Rock Springs Capital Management, LP | 912 | 2.38 |
| Vanguard Group Inc | 868 | 2.27 |
| Citadel Advisors Llc | 711 | 1.86 |
| Balyasny Asset Management LLC | 671 | 1.75 |
| Samsara BioCapital, LLC | 669 | 1.75 |
| Adage Capital Partners GP L.L.C. | 480 | 1.25 |
| 683 Capital Management LLC | 450 | 1.18 |
| Simplify Asset Management, Inc. | 376 | 0.98 |
| Acuta Capital Partners LLC | 354 | 0.93 |
| Baker Brothers Advisors, LLC | 1 | 3.06 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Douglas E. Onsi J.D. | CFO, General Counsel, Treasurer & Secretary, President, CEO & Director | 1.04M | 1969 (56 years) |
| Ms. Christine M. Granfield | VP and Head of Regulatory Affairs & Quality | N/A | 1968 (57 years) |
| Dr. Jason S. Baum Ph.D. | Chief Scientific Officer | N/A | 1979 (46 years) |
| Mr. Augustine J. Lawlor | Chief Operating Officer | 713.57k | 1957 (68 years) |
| Dr. Cynthia A. Sirard M.D. | Chief Medical Officer | 1970 (55 years) | |
| Mr. Mark O'Mahony | Chief Manufacturing Officer | 1971 (54 years) |
Address: United States, Cambridge. MA, 47 Thorndike Street - open in Google maps, open in Yandex maps
Website: https://www.leaptx.com
Website: https://www.leaptx.com
